// App-Quantinova.ai

3795 : Novel and selective MELK kinase inhibitors active in breast cancer cell lines

Researchers

Presenter

  • Patrizia Carpinelli

Principal Investigators

  • Marisa Montemartini

  • Nadia Amboldi

  • Dario Ballinari

  • Sabrina Cribioli

  • Marina Ciomei

  • Riccardo Colombo

  • Stefania Re Depaolini

  • Nilla Avanzi

  • Giulia Canevari

  • Walter Ceccarelli

  • Helena Posteri

  • Maria Gabriella Brasca

  • Daniele Donati

  • Eduard Rudolf Felder

  • Antonella Isacchi

  • Arturo Galvani

  • Alessia Montagnoli

Medical Centers

  • Nerviano Medical Sciences, S.r.l., Nerviano, Italy.

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Triple-negative breast cancer

  • Prostate cancer

  • Breast cancer

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • Progesterone receptor

  • erb-b2 receptor tyrosine kinase 2

  • Maternal Embryonic Leucine Zipper Kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved